These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1543526

  • 1. Studies on DNA damage and induction of SOS repair by novel multifunctional bioreducible compounds. II. A metronidazole adduct of a ruthenium-arene compound.
    Dale LD, Tocher JH, Dyson TM, Edwards DI, Tocher DA.
    Anticancer Drug Des; 1992 Feb; 7(1):3-14. PubMed ID: 1543526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
    Vock CA, Scolaro C, Phillips AD, Scopelliti R, Sava G, Dyson PJ.
    J Med Chem; 2006 Sep 07; 49(18):5552-61. PubMed ID: 16942028
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of topoisomerase II catalytic activity by two ruthenium compounds: a ligand-dependent mode of action.
    Gopal YN, Jayaraju D, Kondapi AK.
    Biochemistry; 1999 Apr 06; 38(14):4382-8. PubMed ID: 10194357
    [Abstract] [Full Text] [Related]

  • 6. Toxicity of [PtCl2(NH3)L] in hypoxia; L = misonidazole or metronidazole.
    Skov KA, Adomat H, Chaplin DJ, Farrell NP.
    Anticancer Drug Des; 1990 Feb 06; 5(1):121-8. PubMed ID: 2156514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V, Nováková O.
    Drug Resist Updat; 2006 Jun 06; 9(3):111-22. PubMed ID: 16790363
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
    Reisner E, Arion VB, Guedes da Silva MF, Lichtenecker R, Eichinger A, Keppler BK, Kukushkin VY, Pombeiro AJ.
    Inorg Chem; 2004 Nov 01; 43(22):7083-93. PubMed ID: 15500346
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C, Bergamo A, Brescacin L, Delfino R, Cocchietto M, Laurenczy G, Geldbach TJ, Sava G, Dyson PJ.
    J Med Chem; 2005 Jun 16; 48(12):4161-71. PubMed ID: 15943488
    [Abstract] [Full Text] [Related]

  • 17. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC, Bacac M, Velders AH, Jansen BA, Kooijman H, Spek AL, Haasnoot JG, Reedijk J.
    J Med Chem; 2003 Apr 24; 46(9):1743-50. PubMed ID: 12699392
    [Abstract] [Full Text] [Related]

  • 18. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
    Magdon E, Schröder E.
    Arch Geschwulstforsch; 1981 Apr 24; 51(3):225-30. PubMed ID: 7271431
    [Abstract] [Full Text] [Related]

  • 19. [Interference of inducible repair processes in Escherichia coli].
    Vasil'eva SV, Iskandarova KA, Makhova EV.
    Genetika; 1989 Dec 24; 25(12):2138-50. PubMed ID: 2517492
    [Abstract] [Full Text] [Related]

  • 20. Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.
    Peacock AF, Habtemariam A, Moggach SA, Prescimone A, Parsons S, Sadler PJ.
    Inorg Chem; 2007 May 14; 46(10):4049-59. PubMed ID: 17441712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.